Screening assays for agonists and antagonists of receptor activator of NF-κB
    1.
    发明授权
    Screening assays for agonists and antagonists of receptor activator of NF-κB 失效
    NF-κB受体激活剂激动剂和拮抗剂的筛选试验

    公开(公告)号:US06884598B2

    公开(公告)日:2005-04-26

    申请号:US09957944

    申请日:2001-09-20

    摘要: The present invention provides methods for screening for a molecule that antagonizes or agonizes RANK activity. One aspect of the invention involves the growth of RANK responsive cells in semi-solid medium, wherein exposure to a RANK antagonist promotes colony formation. Other aspects of the invention rely on promoter/reporter constructs using RANK responsive promoters derived from the MMP-9 and TRAP genes. Additional aspects of the invention exploit the ability of RANK to activate c-src activity, F-actin ring formation and CaPO4 resorption.

    摘要翻译: 本发明提供了筛选拮抗或激化RANK活性的分子的方法。 本发明的一个方面涉及在半固体培养基中RANK反应性细胞的生长,其中暴露于RANK拮抗剂促进集落形成。 本发明的其它方面依赖于使用衍生自MMP-9和TRAP基因的RANK反应性启动子的启动子/报道构建体。 本发明的其它方面利用RANK激活c-src活性,F-肌动蛋白环形成和CaPO 4吸收的能力。

    Screening assays for agonists or antagonists or receptor activator of NF-κB
    6.
    发明授权
    Screening assays for agonists or antagonists or receptor activator of NF-κB 失效
    NF-κB受体激活剂激动剂或拮抗剂的筛选试验

    公开(公告)号:US07572594B2

    公开(公告)日:2009-08-11

    申请号:US11099059

    申请日:2005-04-04

    摘要: The present invention provides methods for screening for a molecule that antagonizes or agonizes RANK activity. One aspect of the invention involves the growth of RANK responsive cells in semi-solid medium, wherein exposure to a RANK antagonist promotes colony formation. Other aspects of the invention rely on promoter/reporter constructs using RANK responsive promoters derived from the MMP-9 and TRAP genes. Additional aspects of the invention exploit the ability of RANK to activate c-src activity, F-actin ring formation and CaPO4 resorption.

    摘要翻译: 本发明提供了筛选拮抗或激化RANK活性的分子的方法。 本发明的一个方面涉及在半固体培养基中RANK反应性细胞的生长,其中暴露于RANK拮抗剂促进集落形成。 本发明的其它方面依赖于使用衍生自MMP-9和TRAP基因的RANK反应性启动子的启动子/报道构建体。 本发明的其它方面利用RANK激活c-src活性,F-肌动蛋白环形成和CaPO 4吸收的能力。